Niemann-Pick C1 Affects the Gene Delivery Efficacy of Degradable Polymeric Nanoparticles
Name
Anderson_Niemann-pick.pdf
Size
2.78 MB
Format
Adobe PDF
Checksum (MD5)
9231890cae7c6b5adfee208ee1c2d7d9
Author(s)
Eltoukhy, Ahmed A.
Sahay, Gaurav
Cunningham, James M.
Anderson, Daniel Griffith
Date Issued
July 2014
Journal
ACS Nano
Publisher
American Chemical Society (ACS)
Citation
Eltoukhy, Ahmed A., Gaurav Sahay, James M. Cunningham, and Daniel G. Anderson. “Niemann-Pick C1 Affects the Gene Delivery Efficacy of Degradable Polymeric Nanoparticles.” ACS Nano 8, no. 8 (August 26, 2014): 7905–13. © 2014 American Chemical Society
Version
Final published version
Abstract
Despite intensive research effort, the rational design of improved nanoparticulate drug carriers remains challenging, in part due to a limited understanding of the determinants of nanoparticle entry and transport in target cells. Recent studies have shown that Niemann-Pick C1 (NPC1), the lysosome membrane protein that mediates trafficking of cholesterol in cells, is involved in the endosomal escape and subsequent infection caused by filoviruses, and that its absence promotes the retention and efficacy of lipid nanoparticles encapsulating siRNA. Here, we report that NPC1 deficiency results in dramatic reduction in internalization and transfection efficiency mediated by degradable cationic gene delivery polymers, poly(β-amino ester)s (PBAEs). PBAEs utilized cholesterol and dynamin-dependent endocytosis pathways, and these were found to be heavily compromised in NPC1-deficient cells. In contrast, the absence of NPC1 had minor effects on DNA uptake mediated by polyethylenimine or Lipofectamine 2000. Strikingly, stable overexpression of human NPC1 in chinese hamster ovary cells was associated with enhanced gene uptake (3-fold) and transfection (10-fold) by PBAEs. These findings reveal a role of NPC1 in the regulation of endocytic mechanisms affecting nanoparticle trafficking. We hypothesize that in-depth understanding sites of entry and endosomal escape may lead to highly efficient nanotechnologies for drug delivery.
MIT Department
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Chemical Engineering
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1021/nn501630h
